NCT07355699 2026-01-21Application of Orelabrutinib With or Without CD20 Monoclonal Antibody in Previously Untreated Marginal Zone LymphomaBeijing Tongren HospitalPhase 4 Recruiting88 enrolled
NCT06134284 2024-06-11Clinical Study of OR for Second-line Treatment of Refractory MZLNingbo No. 1 HospitalPhase 4 Recruiting39 enrolled